Foundayo: New Oral Weight-Loss Pill Approved
Dover News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Eli Lillys Foundayo, a new weight-loss pill, receives FDA approval, joining Novo Nordisks Wegovy. Foundayo, a small-molecule drug, offers a daily oral option for obesity and related issues, with prices ranging from $25 to $349 per month. Studies show it reduces waist size, blood pressure, triglycerides, and cholesterol, with gut-related side effects affecting 5-10% of users. Foundayo is part of a Trump-era deal aiming to reduce GLP-one drug costs, potentially making obesity treatment more accessible.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/9bf4d70b659f6ec3